Written by : Nikita Saha
January 28, 2025
The fresh capital will be used to expand Neko Health’s operations, particularly in the US market. The company also aims to enhance its diagnostic capabilities and establish more clinics to meet rising demand.
Swedish healthtech startup Neko Health, co-founded by Spotify’s Daniel Ek, has raised $260 million in a Series B funding round.
The funding was led by Lightspeed Venture Partners, with participation from General Catalyst, OG Venture Partners, Rosello, Lakestar, and Atomico. The funding has pushed Neko’s post-money valuation to $1.8 billion.
The fresh capital will be used to expand Neko Health’s operations, particularly in the US market. The company also aims to enhance its diagnostic capabilities and establish more clinics to meet rising demand.
“The funding round will allow us to double down and really increase our investments in making the product better,” said Nilsonne.
With a waitlist exceeding 100,000 people—up from 40,000 just months ago—Neko Health has already scanned and evaluated over 10,000 patients in Stockholm and London.
Neko Health operates clinics offering comprehensive health assessments priced at £300. Patients undergo a one-hour examination using proprietary hardware and software that generate millions of health data points.
The process includes detecting skin abnormalities, measuring vital parameters such as blood pressure and cholesterol, and assessing disease risk factors. Post-assessment, patients receive a consultation with a doctor who advises on follow-up care.
Founded in 2018 by Daniel Ek and Hjalmar Nilsonne, Neko Health was conceptualized following a discussion about healthcare on Twitter. Despite their non-medical backgrounds, Ek and Nilsonne spent six years developing the company’s unique approach. Neko is focused on research and development for its medical hardware and software, with plans to release annual updates.